Picture of Aker Biomarine ASA logo

AKBM Aker Biomarine ASA News Story

0.000.00%
no flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMid CapMomentum Trap

Brief: Aker Biomarine Q3 Adjusted EBITDA At USD 24.9 Mln

Nov 1 (Reuters) - Aker Biomarine ASA  AKBM.OL :
    * Q3 REVENUE OF USD 94.6 MILLION, UP 39% FROM USD 67.9
MILLION IN
SAME QUARTER
    * Q3 ADJUSTED EBITDA OF USD 24.9 MILLION, UP 32% FROM USD
18.8
MILLION SAME QUARTER LAST YEAR
    * IN Q3, QRILL AQUA AND SUPERBA WITH 46% AND 51% REVENUE
GROWTH
RESPECTIVELY, MARGIN IMPACTED BY LOW SUPERBA PRODUCTION AND
HIGHER FUEL COST
    * NET SALES IN BRANDS SEGMENT WERE USD 31.1 MILLION FOR Q3,
UP 14%
FROM SAME PERIOD LAST YEAR
    * FOR Q4 2023 WE EXPECT QRILL AQUA REVENUES TO BE ON PAR
WITH SAME
QUARTER LAST YEAR
    * WE EXPECT LONG-TERM AVERAGE ANNUAL SALES GROWTH FOR AKER
BIOMARINE TO BE IN LINE WITH EARLIER COMMUNICATED AMBITIONS AT
AROUND 15%

Source text for Eikon:  ID:nObirZmhna 
Further company coverage:  AKBM.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Aker Biomarine ASA

See all news